Clemens J Q, Calhoun E A, Litwin M S, McNaughton-Collins M, Dunn R L, Crowley E M, Landis J R
Department of Urology, University of Michigan Medical Center, Ann Arbor, MI 48109-5330, USA.
Prostate Cancer Prostatic Dis. 2009;12(3):285-7. doi: 10.1038/pcan.2009.22. Epub 2009 Jun 2.
The National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) is a commonly used 13-item questionnaire for the assessment of symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). For each item, score ranges are 0-1 (6 items), 0-3 (2 items), 0-5 (3 items), 0-6 (1 item) and 0-10 (1 item). This scoring system is straightforward, but items with wider score ranges are de facto weighted more, which could adversely affect the performance characteristics of the questionnaire. We rescored the NIH-CPSI so that equal weights were assigned to each item, and compared the performance of the standard and rescored questionnaires using the original validation dataset. Both the original and revised versions of the scoring algorithm discriminated similarly among groups of men with CP (n=151), benign prostatic hyperplasia (n=149) and controls (n=134). The internal consistency of the questionnaire was slightly better with the revised scoring, but values with the standard scoring were sufficiently high (Cronbach's >or=0.80). We conclude that although the rescored NIH-CPSI provides better face validity than the standard scoring algorithm, it requires additional calculation efforts and yields only marginal improvements in performance.
美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)是一种常用的包含13个条目的问卷,用于评估慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)男性患者的症状严重程度。每个条目的评分范围为0-1(6个条目)、0-3(2个条目)、0-5(3个条目)、0-6(1个条目)和0-10(1个条目)。这种评分系统很简单,但评分范围较宽的条目实际上权重更大,这可能会对问卷的性能特征产生不利影响。我们对NIH-CPSI重新评分,使每个条目具有相等的权重,并使用原始验证数据集比较了标准问卷和重新评分问卷的性能。评分算法的原始版本和修订版本在CP男性组(n=151)、良性前列腺增生组(n=149)和对照组(n=134)之间的区分能力相似。修订评分后问卷的内部一致性略好,但标准评分的数值也足够高(Cronbach's≥0.80)。我们得出结论,尽管重新评分的NIH-CPSI比标准评分算法具有更好的表面效度,但它需要额外的计算工作,并且在性能上仅产生微小的改进。